Publications
Detailed Information
Survival of patients with skeletal metastases from hepatocellular carcinoma after surgical management
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cho, H. S. | - |
dc.contributor.author | Oh, J. H. | - |
dc.contributor.author | Han, I. | - |
dc.contributor.author | Kim, H. -S. | - |
dc.date.accessioned | 2012-07-04T07:12:46Z | - |
dc.date.available | 2012-07-04T07:12:46Z | - |
dc.date.issued | 2009-11 | - |
dc.identifier.citation | JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME; Vol.91-B, No.11; 1505-1512 | ko_KR |
dc.identifier.issn | 0301-620X | - |
dc.identifier.uri | https://hdl.handle.net/10371/78452 | - |
dc.description.abstract | Skeletal metastases from hepatocellular carcinoma are highly destructive vascular lesions
which severely reduce the quality of life. Pre-existing liver cirrhosis presents unique challenges during the surgical management of such lesions. We carried out a retrospective study of 42 patients who had been managed surgically for skeletal metastases from hepatocellular carcinoma affecting the appendicular skeleton between January 2000 and December 2006. There were 38 men and four women with a mean age of 60.2 years (46 to 77). Surgery for a pathological fracture was undertaken in 30 patients and because of a high risk of fracture in 12. An intralesional surgical margin was achieved in 36 and a wide margin in six. Factors influencing survival were determined by univariate and multivariate analyses. The survival rates at one, two and three years after surgery were 42.2%, 25.8% and 19.8%, respectively. The median survival time was ten months (95% confidence interval 6.29 to 13.71). The number of skeletal metastases and the Child-Pugh grade were identified as independent prognostic factors by Cox regression analysis. The method of management of the hepatocellular carcinoma, its status in the liver, the surgical margin for skeletal metastases, the presence of a pathological fracture and adjuvant radiotherapy were not found to be significantly related to the survival of the patient, which was affected by hepatic function, as represented by the Child-Pugh grade. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | BRITISH EDITORIAL SOC BONE JOINT SURGERY | ko_KR |
dc.title | Survival of patients with skeletal metastases from hepatocellular carcinoma after surgical management | ko_KR |
dc.type | Article | ko_KR |
dc.identifier.doi | 10.1302/0301-620X.91B11.21864 | - |
dc.citation.journaltitle | JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME | - |
dc.description.citedreference | Sugiura H, 2008, CLIN ORTHOP RELAT R, V466, P729, DOI 10.1007/s11999-007-0051-0 | - |
dc.description.citedreference | Lin PP, 2007, J BONE JOINT SURG AM, V89A, P1794, DOI 10.2106/JBJS.F.00603 | - |
dc.description.citedreference | Rubin P, 2006, SEMIN RADIAT ONCOL, V16, P120, DOI 10.1016/j.semradonc.2005.12.007 | - |
dc.description.citedreference | PARK KW, 2006, KOREAN J HEPATOL, V12, P41 | - |
dc.description.citedreference | Katagiri H, 2005, J BONE JOINT SURG BR, V87B, P698, DOI 10.1302/0301-620X.87B5.15185 | - |
dc.description.citedreference | Seong J, 2005, LIVER INT, V25, P261, DOI 10.1111/j.1478-3231.2005.01094.x | - |
dc.description.citedreference | MANABE J, 2005, INT J CLIN ONCOL, V10, P103 | - |
dc.description.citedreference | Koizumi M, 2003, ANN ONCOL, V14, P1234, DOI 10.1093/annonc/mdg348 | - |
dc.description.citedreference | Jung ST, 2003, CLIN ORTHOP RELAT R, P223, DOI 10.1097/01.blo.0000059580.08469.3e | - |
dc.description.citedreference | Kurachi K, 2002, J GASTROENTEROL, V37, P571 | - |
dc.description.citedreference | GREENE FL, 2002, AJCC CANC STAGING MA, P131 | - |
dc.description.citedreference | Fukutomi M, 2001, EUR J GASTROEN HEPAT, V13, P1083 | - |
dc.description.citedreference | Liu CL, 2001, J CLIN ONCOL, V19, P3725 | - |
dc.description.citedreference | Tomita K, 2001, SPINE, V26, P298 | - |
dc.description.citedreference | TANAKA H, 2001, GAN TO KAGAKU RYOHO, V28, P151 | - |
dc.description.citedreference | El-Serag HB, 1999, NEW ENGL J MED, V340, P745 | - |
dc.description.citedreference | Kaizu T, 1998, AM J GASTROENTEROL, V93, P2167 | - |
dc.description.citedreference | Lam CM, 1998, BRIT J SURG, V85, P1198 | - |
dc.description.citedreference | ARII S, 1998, J HEPATO-BILIARY-PAN, V5, P86 | - |
dc.description.citedreference | Murakami R, 1996, BRIT J RADIOL, V69, P1042 | - |
dc.description.citedreference | YAMASHITA K, 1993, CANCER, V71, P1297 | - |
dc.description.citedreference | ENNEKING WF, 1993, CLIN ORTHOP RELAT R, P241 | - |
dc.description.citedreference | TAKI Y, 1992, J SURG ONCOL, V50, P12 | - |
dc.description.citedreference | YAMASHITA K, 1991, CANCER, V68, P634 | - |
dc.description.citedreference | TOKUHASHI Y, 1990, SPINE, V15, P1110 | - |
dc.description.citedreference | MIRELS H, 1989, CLIN ORTHOP RELAT R, P256 | - |
dc.description.citedreference | LOAW CC, 1989, CANCER, V64, P1753 | - |
dc.description.citedreference | CLARKSTON W, 1988, J CLIN GASTROENTEROL, V10, P221 | - |
dc.description.citedreference | LEE YTM, 1987, J SURG ONCOL, V36, P26 | - |
dc.description.citedreference | 1984, CANCER, V54, P1747 | - |
dc.description.citedreference | NAKASHIMA T, 1983, CANCER, V51, P863 | - |
dc.description.citedreference | CHEARANAI O, 1983, CANCER, V51, P1532 | - |
dc.description.citedreference | PUGH RNH, 1973, BRIT J SURG, V60, P646 | - |
dc.description.citedreference | KEW MC, 1971, BRIT MED J, V4, P408 | - |
dc.description.citedreference | CHILD CG, 1964, MAJOR PROBL CLIN SUR, V1, P1 | - |
dc.description.tc | 0 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.